Symphogen, a Swedish biopharmaceutical firm, has named Mads Laustsen as its chief manufacturing officer. The appointment becomes effective June 1. Previously, Laustsen was one of the founders of CMC Biologics and served as the company’s CEO from 2001 until May 2011. Also, Symphogen has relocated its corporate headquarters in Lyngby, Denmark to Ballerup, a suburb of Copenhagen. Symphogen’s backers include Novo, Essex Woodlands Health Ventures and PKA.